LeMaitre Vascular logo

LeMaitre Vascular

LMAT | NASDAQ
Chart Builder DCF Calculator
$77.01
-$1.28 (-1.63%)
At close: Nov 16, 2026, 4:00 PM ET
$77.01
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-1.63%

Rating

Updated: Nov 16, 2026
69.1
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #65/1021 (Top 6%)

Key Statistics

Market Data

Market Cap $1.76B
1D Range
76.60 78.37
52W Range
76.60 117.39

Valuation (TTM)

PE 28
PB 4.08
EV/EBITDA 17.04

Valuation (NTM)

Forward PE 27.96
Forward PEG 2.05
Price Target $95.00
Loading financial charts...

Profile

Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfol...

Sector Healthcare
Employees 651
IPO Date Oct 19, 2006
Fiscal Year January - December

Latest News

LeMaitre Vascular, Inc. (LMAT) Q3 2026 Earnings Call Transcript

10 days ago · seekingalpha.com

LeMaitre Vascular, Inc. (LMAT) Q3 2026 Earnings Call Transcript
LeMaitre to Participate in Upcoming Investor Conferences

10 days ago · globenewswire.com

LeMaitre to Participate in Upcoming Investor Conferences
LeMaitre Vascular Q3 Earnings Call Highlights

12 days ago · marketbeat.com

LeMaitre Vascular Q3 Earnings Call Highlights
LeMaitre Vascular (LMAT) Misses Q3 Earnings Estimates

12 days ago · zacks.com

LeMaitre Vascular (LMAT) Misses Q3 Earnings Estimates
LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026

1 month ago · globenewswire.com

LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026
LeMaitre Vascular: The Q2 Miss Hides A Stronger Acquisition Machine

2 months ago · seekingalpha.com

LeMaitre Vascular: The Q2 Miss Hides A Stronger Acquisition Machine
LeMaitre to Participate at Upcoming Investor Conferences in September

3 months ago · globenewswire.com

LeMaitre to Participate at Upcoming Investor Conferences in September
LeMaitre Vascular: 31% Drawdown On $0.02 Guidance Cut

3 months ago · seekingalpha.com

LeMaitre Vascular: 31% Drawdown On $0.02 Guidance Cut
LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

3 months ago · globenewswire.com

LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
LeMaitre Vascular, Inc. (LMAT) Q2 2026 Earnings Call Transcript

3 months ago · seekingalpha.com

LeMaitre Vascular, Inc. (LMAT) Q2 2026 Earnings Call Transcript

Earnings

Latest Earnings
Nov 4, 2026
EPS
$0.65
Miss -5.25%
REV
$67.97M
Beat +0.86%
Next Earnings
Feb 24, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
4
Consensus
Buy
Price Target
$95.00
Upside
+23.36%
Buy (3)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.